13th Annual USC Multi-Disciplinary Breast Cancer Symposium

Add to Calendar 13th Annual USC Multi-Disciplinary Breast Cancer Symposium 1/17/2026 7:55:00 AM 1/17/2026 4:35:00 PM America/Los_Angeles For More Details: https://keckusc.cloud-cme.com/breastcancer2026 Description: This program reviews the current state-of-the-art for breast cancer management, highlighting the key components of multi-disciplinary treatment to include oncofertility, breast pathology, surgical oncology, medical oncology, and radiation oncology. The format of this program consists of lectures by international experts in their fields. Over the past year, advances in clinical trials have demonstrated the utility o... SLS Hotel false MM/DD/YYYY


Date & Location
Saturday, January 17, 2026, 7:55 AM - 4:35 PM, SLS Hotel, Beverly Hills, CA

Credits
AMA PRA Category 1 Credits™ (7.25 hours), Non-Physician Attendance (7.25 hours)

Overview

This program reviews the current state-of-the-art for breast cancer management, highlighting the key components of multi-disciplinary treatment to include oncofertility, breast pathology, surgical oncology, medical oncology, and radiation oncology. The format of this program consists of lectures by international experts in their fields.

Over the past year, advances in clinical trials have demonstrated the utility of antibody-drug conjugates, molecular detection of residual disease, and downstaging surgical management of the axilla. These developments, along with data on resistance to endocrine therapy, updates in the use of artificial intelligence in breast cancer detection and diagnostics, therapy targeting the HER2 axis, and breast cancer risk in patients having gender affirming surgery, make individualized management decisions increasingly important in treating patients with breast cancer. Newer radiation therapy treatment strategies and clinical trials in radiation oncology continue to evolve. These breakthroughs allow personalized breast cancer treatments to maximize benefits and minimize treatment toxicities.

The symposium focuses on advances neoadjuvant adjuvant hormone therapy, new hormone receptors in breast cancer, surgical management of the axilla, clinical trials in radiation therapy, oncofertility, the use of identifying circulating tumor DNA in the blood after treatment, and evolving strategies in HER2-positive breast cancer.


Objectives

By the end of the course, participants will be able to: 


  1. Understand the role of novel diagnostic tools for breast cancer including cDNA and AI.
  2. Assess the risk of breast cancer in patients undergoing gender-affirming care.
  3. Explain the importance of fertility preservation during breast cancer treatment.
  4. Discuss appropriate use of ADCs and HER2 directed therapies.
  5. Identify the controversies regarding the role of radiation therapy in DCIS.
  6. Assess decision-making process in surgical management of the axilla.
  7. Incorporate the evolving role of clinical trials in radiation therapy.
  8. Define the role of neoadjuvant and novel endocrine therapy.
  9. Recognize an evolving role of Androgen and Glucocorticoid Receptors in breast cancer.

Accreditation
The Keck School of Medicine of the University of Southern California is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Keck School of Medicine of the University of Southern California designates this Live Activity activity for a maximum of 7.25 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 


Additional Information

Cancellation Policy

Cancellations must be received by the USC Office of CME by email only by January 13, 2026 at 12:00 pm PT for a refund. A $50 cancellation fee will be applied. In the event of course cancellation by conference organizers, all registration fees will be fully refunded. USC will not refund any travel costs incurred.


Accessibility Statement
 
Keck School of Medicine Healthcare System is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008. If you have needs that require special accommodations, including dietary concerns, please contact the USC Office of CME at [email protected].